Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.-临床诊疗知识库

首页 > Hematology/oncology and stem cell therapy > Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characterist...

收藏 | 浏览20

Plasma cell leukemia (PCL) is a rare hematologic malignancy with very poor outcome. It is defined by the presence of >2 × 10(9)/L plasma cells or >20

作者：Nahlah, Alghasham；Randa, Alnounou；Hazzaa, Alzahrani；Fahad, Alsharif

来源：Hematology/oncology and stem cell therapy 2015 年 8卷 2期

循证诊断

相似文献

[1]IgA plasma cell leukemia.《Journal of laboratory physicians》 2009 年 1卷 1期
[2]Synchronous Plasma Cell Myeloma and Acute Myeloid Leukemia in a Therapy-Na?ve Patient: A Rare Occurrence.《Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion》 2016 年 32卷 Suppl 1期
[3]Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation.《International medical case reports journal》 2012 年 5卷
[4]Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns.《Oncotarget》 2015 年 6卷 19期
[5]Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib.《Hematology reports》 2016 年 8卷 1期
[6]A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.《Oncotarget》 2015 年 6卷 28期
[7]Plasma cell leukemia: from biology to treatment.《European journal of haematology》 2015 年 95卷 1期
[8]Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.《International journal of laboratory hematology》 2015 年 37卷 6期
[9]Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.《Oncotarget》 2017 年 8卷 12期
[10]Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.《Oncotarget》 2015 年 6卷 27期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求，方便快速、便捷的获取实用的医学信息，辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍

热门关注

免责声明：本知识库提供的有关内容等信息仅供学习参考，不代替医生的诊断和医嘱。